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Five decades ago, Hayflick and Moorhead first describ-
ed the phenomenon  of  limited  replicative  capacity  of 
 
cultured primary cells, termed cellular re-plicative 
senescence [1, 2]. It was postulated that this in vitro (i.e. 
in cultured cells) phenomenon of stable cell cycle arrest 
might be related to aging of the whole organisms in vivo 
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Little  is  known on how well  senescence markers  in  vitro  and  in  situ  correlate within  individual donors. We
studied  correlations  between  the  same  and  different  in  vitro markers.  Furthermore, we  tested  correlations
between in vitro markers with in situ p16INK4a positivity. 
From 100 donors  (20‐91 years), cultured dermal  fibroblasts were assessed  for  reactive oxygen species  (ROS),
telomere‐associated  foci  (TAF),  p16INK4a  and  senescence‐associated  β‐gal  (SAβ‐gal), with/ without  0.6  µM
rotenone  for 3 days  (short‐term).  In  fibroblasts  from 40 donors,  telomere shortening, ROS and SAβ‐gal were
additionally  assessed, with/ without  20  nM  rotenone  for  7 weeks  (long‐term).  In  skin  from  52  donors,  the
number of p16INK4a positive dermal cells was assessed in situ. 
More than half of the correlations of the same senescence markers in vitro between duplicate experiments and
between  short‐term versus  long‐term experiments were  significant. Half of  the different  senescence marker
correlations  were  significant  within  the  short‐term  and  within  the  long‐term  experiments.  The  different
senescence markers in vitro were not significantly correlated intra‐individually with in situ p16INK4a positivity.
In  conclusion,  the  same  and  different  senescence  markers  are  frequently  correlated  significantly  within  and
between in vitro experiments, but in vitro senescence markers are not correlated with p16INK4a positivity in situ.
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(i.e. in living organisms). Since then many studies have 
focussed on cellular senescence in vitro, and have 
identified several triggers inducing senescence as well 
as pathways leading to senescence (reviewed in [3]). 
Considerable interest has also been given to the possible 
in vivo implications of senescence; by studying relevant 
functions, including embryonic development and 
attenuating liver fibrosis as well as consequences of 
senescence in animal models, notably age-related 
diseases, and tumorigenesis [4-8]. In the last few 
decades [9] tissues have been studied to detect cellular 
senescence in situ (i.e. in tissue), providing knowledge 
on the prevalence of senescent cells in humans at older 
ages or with disease. 
 
Apart from growth arrest, several other markers of 
cellular senescence have been studied (reviewed in 
[10]). A frequently used marker is senescence-
associated β- galactosidase (SAβ-gal) activity, which is 
upregulated in, but not essential for senescence [9, 11]. 
Other markers are based on triggers of senescence such 
as DNA damage foci or reactive oxygen species (ROS), 
expression of genes involved in cell cycle arrest or 
factors that are secreted by senescent cells [3, 10, 12]. 
Most of these markers have been established by 
detecting senescence in vitro, but some can also be used 
in situ [13]. However, the number of studies on 
fibroblasts reporting on senescence in situ compared 
to in vitro is disproportionally small [14], and there is 



























senescence markers between these conditions. In 
addition, only a few attempts have been made to study 
the correlation between different senescence markers. 
 
Our aim is to study the correlations between the same 
senescence markers (A) and between different 
senescence markers within individual donors (B), using 
a unique dataset of highly standardized experiments. 
These experiments included in vitro short-term 
experiments (1); in vitro long-term experiments (2), and  
in situ  experiments within skin biopsies (3). First we 
investigated correlations between the same senescence 
markers: in vitro between duplicate experiments (1A)  
and in vitro between short-term and long-term 
experiments (2A). In addition, we investigated 
correlations between different senescence markers: 
between in vitro markers within the same short-term 
experiments (1B); between in vitro markers within the 
same long-term experiments (2B); and intra-
individually between in vitro markers and in situ 




Characteristics of donors 
 
Table 1 summarizes the anthropometric and medical 
characteristics of the donors from whom the skin 
biopsies were obtained based on age (young, mean 23 




























Young Middle-aged Old Subset* 
  (N=10)   (N=80)   (N=10)   (N=52) 
Female, no.(%) 7 (70.0) 40 (50.0) 6 (60.0) 25 (48.1) 
Age, years 22.8 (1.5) 63.2 (7.3) 90.2 (0.5) 64.2 (6.9) 
Member of long-lived family n/a 40 (50.0) n/a 26 (50.0) 
Body mass index, kg/m² 22.2 (1.8)a 26.2 (4.1)b 25.4 (3.8) 25.9 (4.3) 
Co-morbidities 
  Cerebrovascular accident 0/10 (0.0) 3/76 (3.9)  2/10 (20.0) 3/51 (5.9) 
  Chronic obstructive pulmonary disease 0/10 (0.0) 3/75 (4.0) 1/10 (10.0) 1/51 (2.0) 
  Diabetes mellitus 0/10 (0.0) 7/74 (9.5) 2/10 (20.0) 4/51 (7.8) 
  Hypertension 0/10 (0.0) 17/76 (22.4) 5/10 (50.0) 15/52 (28.8) 
  Malignancies 0/10 (0.0) 3/72 (4.2) 1/10 (10.0) 1/50 (2.0) 
  Myocardial infarction 0/10 (0.0) 0/75 (0.0) 3/10 (30.0) 1/52 (1.9) 
  Rheumatoid arthritis 0/10 (0.0) 0/76 (0.0) 3/10 (30.0) 0/52 (0.0) 
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Correlations between the same senescence markers 
 
First, we studied correlations between the same 
markers, both in non-stressed and stressed conditions. 
The correlation of duplicates of each senescence marker 
(p16INK4a, telomere associated foci - TAF, reactive 
oxygen species - ROS and senescence-associated β-gal - 
SAβ-gal) were tested between experiment I and II of the 
short term experiments (Table 2). Most markers showed 















































(coefficients > 0.400), except for ROS which showed 
low, non-significant correlation coefficients.  
  
Table 3 shows the correlations between ROS and SAβ-
gal in the short-term versus the long-term experiments. 
The mean of ROS measures in the short-term 
experiment were significantly correlated to ROS in the 
long-term experiment. SAβ-gal was not significantly 
















































Distribution of markers 
  Experiment I Experiment II Correlation coefficient P-value 
Non-stressed 
  p16INK4a, % 0.90 (0.45; 1.65) 1.61 (0.76; 2.71) 0.702 <0.001   
  TAF, %/nucleus 24.2 (16.9; 31.0) 24.4 (18.5; 32.1) 0.418 <0.001   
  ROS, FI 1477 (1280; 1706) 1455 (1295; 1762) -0.111 0.354 
  SAβ-gal, FI 2959 (2389; 3813) 2987 (2187; 3951) 0.527 <0.001   
Stressed 
  p16INK4a, % 2.17 (1.10; 4.17) 4.70 (2.33; 6.48) 0.623 <0.001   
  TAF, %/nucleus 20.6 (14.8; 27.9) 21.9 (16.0; 26.7) 0.414 <0.001   
  ROS, FI 2003 (1734; 2376) 1972 (1653; 2366) 0.139 0.244 
  SAβ-gal, FI 4251 (3405; 5345) 4044 (3180; 5233) 0.452 <0.001   
N=100. Marker distribution  is given as median  (IQR). Correlations are Pearson’s partial correlation coefficient, 
adjusted  for batch. All markers  in  experiment  I were  correlated with  the  same markers  in  experiment  II.  FI: 
fluorescence  intensity.  P16INK4a:  percentage  of  p16INK4a  positive  cells;  TAF  (telomere  associated  foci): 
percentage of nuclei with ≥1 TAF/nucleus; ROS: mean fluorescence intensity peak reactive oxygen species; SAβ‐
gal: median fluorescence intensity peak senescence‐associated β galactosidase. 
Table  3.  Senescence  markers  and  their  correlations  between  short‐term  versus  long‐term 
experiments (2A). 
Distribution of markers 
  Short-term experiment Long-term experiment Correlation coefficient P-value 
Non-stressed 
  ROS, FI 1559 (1356; 1734) 1500 (1366; 2205) 0.419 0.010 
  SAβ-gal, FI 2973 (2445; 3732) 3452 (2905; 4660) -0.009 0.959 
Stressed 
  ROS, FI 2095 (1753; 2324) 1835 (1553; 2205) 0.426 0.009 
  SAβ-gal, FI 4171 (3530; 5231) 4090 (3417; 5205) -0.006 0.972 
N=40. Correlations are Pearson’s partial correlation coefficient, adjusted for batch. All mean markers of short‐term 
experiments  I  and  II  were  correlated  with  the  same  markers  in  the  long‐term  experiment.  FI:  fluorescence 
intensity. ROS: mean fluorescence intensity peak reactive oxygen species; SAβ‐gal: median fluorescence intensity 
peak senescence‐associated β galactosidase. 
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The raw data points of the same markers between 
















































































































Figure  1.  Correlation  plots  of  the  same  senescence  markers  between  duplicate  experiments  and
between  short‐term  versus  long‐term  experiments.  Each  dot  represents  an  individual  donor,  N=40‐100.
Uncorrected  (not  log  transformed) data points are  shown. P16INK4a: percentage of p16INK4a positive cells; TAF
(telomere  associated  foci):  percentage  of  nuclei  with  ≥1  TAF/nucleus;  ROS:  mean  fluorescence  intensity  peak
reactive oxygen species; SAβ‐gal: median fluorescence  intensity peak senescence‐associated β galactosidase. For the
between short‐term and long‐term experiment correlations, in vitro variables are the mean of short‐term experiments.

























Correlations between different senescence markers 
 
Second, we studied correlations between different 
senescence markers. In the Supplementary Material, 
correlations between different senescence markers within 
the short-term (Supplementary Table 1) and long-term 
experiments (Supplementary Table 2) are given. In the 
short-term experiment each marker was tested against the 
3 other markers, both in non-stressed (6 combinations) 
and stressed condition (6 combinations). Of these 12 
senescence marker combinations, 6 were significantly 
correlated (in non-stressed and stressed conditions 3 
each). P16INK4a showed the highest correlations with 
other markers. In the long-term experiment a total of 6 
marker combinations were tested in both non-stressed 
and stressed conditions of which 3 senescence marker 
combinations were significantly correlated, mainly with 
ROS (2 in the non-stressed condition, 1 in the stressed 
condition). Using telomere length instead of telomere 
shortening reduced the amount of significant markers 
combination correlations, indicating a difference in 
telomere length and telomere shortening over time as 
senescence markers. In vitro senescence markers (both in 
non-stressed and stressed conditions) were tested for 
correlation with in situ p16INK4a positivity of dermal 
fibroblasts (Table 4). No significant correlations were 
observed between in situ p16INK4a positivity and any of 
the in vitro senescence markers (ROS, TAF, SAβ-gal or 
p16INK4a). In Figure 2, in vitro p16INK4a positivity in 
non-stressed and stressed conditions are plotted against in 
situ p16INK4a positivity of dermal fibroblasts, further 
























































  Coefficient P-value 
Non-stressed 
    p16INK4a 0.064 0.655 
    TAF -0.030 0.835 
    ROS -0.097 0.498 
    SAβ-gal -0.042 0.772 
Stressed 
    p16INK4a 0.091 0.527 
    TAF 0.014 0.922 
    ROS -0.095 0.506 
    SAβ-gal 0.023 0.871 
Values are depicted as Pearson's partial correlation coefficient, adjusted for batch. Data for  in situ 





Figure 2.  Intra‐individual  correlations:  in  vitro versus  in
situ  p16INK4a  positivity.  Each  dot  represents  an  individual
donor, N=52. In vitro p16INK4a positivity: percentage of p16INK4a
positive  cells  ‐ mean  of  experiments  I  and  II.  In  situ  p16INK4a
positivity:  number  of  p16INK4a  positive  cells  per  1mm2  dermis.
Uncorrected (not log transformed) data points are shown. 
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In individual donors, half of the correlations of the same 
senescence markers in vitro were significant between 
duplicate experiments (1A) and between short-term 
versus long-term experiments (2A). Within the 
experiments the different senescence markers were 
significantly correlated to each other in half of the 
correlations tested, both in short-term (1B) and long-
term experiments (2B). In general, correlation co-
efficients were lower as compared to those calculated 
for the same senescent markers. Assessment of 
correlations between in situ p16INK4a positivity with 
different in vitro senescence markers showed a lack of 
correlation, both with in vitro markers in non-stressed 
and stressed conditions (3B). 
 
Most correlations between duplicate experiments show 
that the experiments were adequately reproducible, 
suggesting that the influence of technical issues was 
limited. However, ROS showed poor reproducibility 
between duplicates which hampers interpretation of 
other tested correlations with ROS. The fact that no 
correlation coefficient above 0.702 was observed 
indicates that despite highly standardized conditions, 
the assays used are inherently prone to variation. 
Although the same markers were also correlated 
between the short-term and long-term experiments, this 
was less often the case than for the between duplicate 
experiment correlations. This finding is not surprising, 
as cell strains of an individual could respond to short-
term and long-term stress differently. In our previous 
study we showed that  SAβ-gal in the stressed condition 
in the short-term experiment was negatively associated 
with the maximum replicative capacity of the strain (a 
long-term outcome), whereas a positive but non-
significant trend was seen in the non-stressed condition 
[15]. 
 
Senescence can be triggered in response to multiple 
factors and be induced through different pathways. 
Therefore it has been advised to use a marker of cell 
cycle arrest plus a minimum of two senescence markers 
[16]. Studies on senescence markers in single cells 
show that there is not a hundred percent concordance of 
different markers , for e.g. p16 and SAβ-gal [17], p16 
and p21 [18], and γH2AX foci and p21 [19]. One of 
these studies also showed that SAβ-gal, senescence 
associated heterochromatin foci and the combination of 
Ki67 with γH2A.X foci were superior to other marker 
combinations in predicting growth curves of MRC5 
fibroblast cultures [19]. A recent review [13] discussed 
the shortcomings of frequently used markers to assess in 
vitro senescence and particularly the difficulties of 
using these markers to detect in vivo senescence. It is a 
topic under debate in a still rapidly evolving field. We 
confirm the importance of this stance based on our 
results on correlations between different senescence 
markers. Only a half of the tested senescence marker 
combinations were significantly correlated within the 
experiment. The in vitro senescence marker that was 
most correlated to other in vitro senescence markers 
was p16INK4a. This was also the marker with the 
highest correlation coefficient between experiment I and 
II (between duplicate experiments). This good 
correlation of duplicates could thus explain the 
observation that p16INK4a correlated most frequently 
to the other markers, and overall appears to be the most 
robust in vitro senescence marker from the set of 
markers tested here.  
 
A recent review has shown that while some in vitro 
observations on fibroblast aging have also been 
observed in situ in skin tissue, many observations have 
not been tested in situ yet [14]. To our knowledge, this 
is the first study in humans to directly correlate 
senescence markers in vitro and in situ in cultured 
fibroblasts and biopsies from the same individual to 
assess whether both are reflective of a common 
(epi)genetic propensity to induce cellular senescence. In 
mice microRNA expression profiles were compared in 
cultured cells and aged mouse brains, which showed 
only very little similarities in expression [20]. The lack 
of correlation between in vitro and in situ senescence 
markers we have observed, was not altogether 
surprising. While experimental set-ups allow controlling 
of many variables, this also decreases the natural 
context of human cells. It has been observed that the 
process of establishing fibroblasts strains from skin 
biopsies itself can result in a selection of a subgroup of 
fibroblasts. Fibroblasts from subsequent outgrowths of 
single skin biopsies were shown to differ in their 
proliferation capacities [21]. Outgrowth from different 
dermal layers results in higher culture survival time in 
fibroblasts from the papillary dermis compared to 
reticular dermis [22, 23]. Hence, in vitro fibroblasts 
might only relate to a small sub-population of 
fibroblasts in situ and study of this sub-population in 
situ might be needed to detect any correlations. In 
addition, different culturing conditions were shown to 
have effects on replicative lifespan as well [24], and the 
process of cell culture itself has been suggested to drive 
some of the senescence findings in vitro [25, 26]. We 
used atmospheric oxygen culture conditions which in 
itself is thought to be a stressor [27]. This can be seen in 
our scatterplot showing some individuals with high 
p16INK4a positivity in situ and low p16INK4a 
positivity in vitro, which might have resulted from 
selection of senescence resistant fibroblasts during 
expansion. Furthermore, a small biopsy from one 
location of a donor might not reflect the entire tissue or 
entire organism adequately. It is also not clear how a 
fluctuating physiological state of a donor can influence 
the samples tissue. Overall, in vitro experimental data 
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from cells derived from one individual might not be 
representative for the cell populations in their tissues 
under in vivo conditions. Due to this lack of intra-
individual correlation, difficulty might arise in extra-
polating observations from in vitro experiments to in 
vivo implications. On the other hand, perhaps the in 
vitro characteristics of the selected subpopulation of 
primary cells could still reflect in vivo cellular 
capacities in specific situations, such as disease or in the 
presence of environmental stressors.  
 
This study uses unique data on multiple senescence 
markers in vitro established from 100 individual 
fibroblast strains. We regard the high number of 
fibroblast strains as a strong point of this study. All 
culturing procedures and experiments were conducted 
under highly standardized conditions, and our results 
here highlight the need for maximally standardize the 
operating procedures. We measured senescence markers 
in cultures that were in phase IIa, and thus just a 
fraction of cells were senescent, reflecting the mix of 
dividing and senescent cells within the human body. 
Studying correlations in only non-dividing cultures 
might yield different findings. A limitation of the study 
is that we did not include a marker for proliferation such 
as Ki-67. The association between in vitro and in situ 
p16INK4a positivity could only be evaluated in 52 
middle aged subjects that had both measurements, 
which limited the power to detect significant 
correlations.  Another limitation of the present study is 
at the same time a limitation of many human studies in 
general: we have detected p16INK4a in situ, but cannot 
(yet) study cellular senescence in vivo in humans. 
Studies aiming to detect cellular senescence in vivo in 
animal models have shown high inter-individual 
variability, especially at older ages [28, 29]. Inter-
individual variation of senescence might also be 
influenced by genetic polymorphisms. In human 
peripheral blood T-cells, one atherosclerotic disease-
related SNP was shown to associate with decreased 
expression of INK4/ARF transcripts [30]. Further 
analysis of intra-individual correlation between in vitro 
and in vivo senescence associated markers within 
animal models could help to better explore this lack of 
correlation. Another limitation of our study is that for in 
situ measurements we only have data of one senescence 
marker, p16INK4a, whilst consensus is lacking on 
which (panel of) markers should be used to 
appropriately detect senescent cells in situ.  
 
In conclusion, on an individual donor level the same 
markers of senescence in vitro, and to a lesser extent 
different markers of senescence, are frequently signi-
ficantly correlated within and between experiments. In 
vitro senescence markers and in situ fibroblast 
p16INK4a positivity were not correlated. Caution is 
warranted when interpreting results from in vitro 






The Leiden 85-plus Study is a prospective population-
based study [31] in which inhabitants of Leiden (the 
Netherlands) were invited to participate upon reaching 
the age of 85 years between 1997 and 1999. Several 
phenotypes of participants were collected, amongst 
them information on chronic diseases, disabilities, 
cognitive function and well-being. In order to study in 
vitro fibroblast characteristics based on large 
chronological age differences participants aged 90 years 
from the Leiden 85-plus cohort donated skin biopsies of 
the upper inner arm together with young voluntary 
controls aged 18-25 years [32]. As previously described 
[33], in the Leiden Longevity Study factors contributing 
to familial longevity are studied. Long-lived siblings 
(men aged 89 years or over, women age 91 years or 
over) were included, as well as their offspring who are 
assumed to have a familial propensity for longevity as 
well. The partners of these offspring were included in 
former studies as controls, as they are of similar age and 
share the same environment. Skin biopsies for in situ 
staining and fibroblast cultures were obtained from 
middle-aged to old (mean 63 years) offspring of 
nonagenarian sibling and their partners. All 
participants in these studies have given written 
informed consent, and both studies were approved by 
the Medical Ethical Committee of the Leiden 
University Medical Center.  
 
In vitro senescence markers 
 
Detailed methods have been described previously [34-
36]. In short, fibroblast strains from 10 young donors 
(passage 14), from 80 middle-aged donors (40 offspring 
of long-lived families and 40 partners – passage 10), 
and from 10 old donors (passage 14) were randomly 
selected for subsequent experiments. Fibroblasts were 
cultured for 3 days with or without 0.6 µM rotenone (a 
mitochondrial complex I inhibitor) added to the medium 
(short-term experiments). Senescence can be triggered 
by stressors such as ROS-induced damage through 
rotenone [16, 37].  
 
Adding a stressor can show cellular responses to stress-
induced damage, in addition to mainly replicative 
senescence in non-stressed conditions. The following 
senescence markers were assessed in fibroblast cultures 
in non-stressed and in rotenone-stressed conditions: β 
galactosidase (SAβ-gal), reactive oxygen species 
(ROS), p16INK4a positivity and telomere-associated 
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foci (TAF). Fluorescence intensities were measured 
using flow cytometry, resulting in median fluorescence 
intensity values of SAβ-gal and mean fluorescence 
intensity values of ROS. The percentages of immuno-
cytochemically stained p16INK4a positive fibroblasts 
were determined. The number of telomere-associated 
foci (TAF) was determined using immunofluorescence 
and PNA telomeric probe (53BP1 positive foci located 
at telomeres). 100 randomly selected nuclei were 
automatically scored for TAF. TAF are presented as the 
percentage of nuclei with ≥1 TAF per nucleus. These 
experiments were conducted in duplicate (experiments I 
and II) [34, 36] (i.e. in parallel conducted repeated 
experiments for each strain – at passage 14 a donors 
culture was split and experiment I was performed 
during 3 days (both stressed and non-stressed 
condition); after one week the other half of the culture 
underwent the same procedure, which was experiment 
II.). Furthermore, alongside the above mentioned 
experiments, 10 fibroblast strains from young, 20 from 
middle-aged (10 offspring, 10 partners) and 10 from old 


































weeks, with or without 20 nM rotenone to generate 
chronic stress (long-term experiments). The median-
fluorescence intensity values of β galactosidase (SAβ-
gal) and reactive oxygen species (ROS) were measured 
using flow cytometry. Telomere length was assessed 
with a flow-FISH kit and was expressed as the 
percentage compared to the reference cell line. The 
telomere shortening rate was further determined by 
comparing these measurements to telomere length at 
baseline and dividing the difference by the number of 
cumulative population doublings [35].  
 
In situ senescence marker 
 
As detailed previously [38], in order to detect 
p16INK4a in the formalin fixed paraffin embedded skin 
tissue, immunohistochemistry staining was used. 
Dermal p16INK4a positive cell counts were restricted 
to morphologically determined fibroblasts and 
normalized for the area of the dermis in which the cells 
were counted. Dermal p16INK4a positivity is given as 




































Figure  3.  Explanation  of  hypotheses  tested. TAF:  telomere  associated  foci.  ROS:  reactive  oxygen  species.  SAβ‐gal:
senescence‐associated β galactosidase. 
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Statistics 
 
All analyses were performed using IBM SPSS Statistics 
20. Not all data was normally distributed and these 
variables were naturally log transformed before 
evaluating the correlations by calculating the Pearson 
partial correlation coefficient, adjusted for experiment 
batch. The studied correlations are explained in Figure 
3. First, correlations of the same senescence markers 
were analyzed using data of the short-term experiments 
I and II (duplicate experiments) (1A); the mean results 
of duplicates in the short-term experiments and the 
single measurements of the long-term experiments (as 
this experiment was performed once) (2A). Secondly, 
correlations between different senescence markers were 
analyzed using the mean results of duplicates within the 
short-term experiments (1B); the single measurements 
within the long-term experiment (2B); and the mean of 
the in vitro markers in the short-term experiments 
(mean results of duplicates) and in situ p16INK4a 
positivity (3B). For the latter correlation a subset of 
N=52 donors was used that had senescence markers 
measured both in their cultured fibroblasts (in vitro) and 
in their skin biopsies (in situ). All in vitro markers were 
measured in a non-stressed and (rotenone) stressed 
condition. For data visualization the percentage of 
fibroblasts staining positive for p16INK4a in vitro was 
plotted against the number of p16INK4a positive 
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  p16INK4a TAF ROS SAβ-gal 
Non-stressed 
  p16INK4a n/a - - - 
  TAF 0.253 (0.011) n/a - - 
  ROS 0.321 (0.001) -0.048 (0.636)  n/a - 
  SAβ-gal 0.151 (0.134) 0.054 (0.598) 0.232 (0.021) n/a 
Stressed 
  p16INK4a n/a - - - 
  TAF 0.227 (0.024) n/a - - 
  ROS 0.299 (0.003) 0.038 (0.706) n/a - 
  SAβ-gal 0.162 (0.109) 0.215 (0.032) 0.115 (0.255) n/a 
N=100.  Values  are  depicted  as  Pearson’s  correlation  coefficient  (P‐value),  partial  correlation with  adjustment  for  batch.  n/a:  not 
applicable. P16INK4a: % of p16 positive cells; Telomere‐associated foci (TAF): % of nuclei with ≥1 53BP1 foci coinciding with telomeric 




  ROS SAβ-gal Telomere shortening 
Telomere length 
Non-stressed  
  ROS n/a - - - 
  SAβ-gal 0.341 (0.042) n/a - - 
  Telomere 
shortening -0.466 (0.004)  -0.011 (0.949)  n/a 
n/a 
  Telomere length -0.100 (0.550) 0.280 (0.093) n/a n/a 
 
Stressed  
  ROS n/a - - - 
  SAβ-gal 0.436 (0.008) n/a - - 
  Telomere 
shortening -0.220 (0.198)  -0.030 (0.862)  n/a 
n/a 
  Telomere length 0.156 (0.358) 0.276 (0.104) n/a n/a 
N=40. Values are depicted as Pearson’s correlation coefficient (P‐value), partial correlation with adjustment 
for  batch.  n/a:  not  applicable.  ROS:  mean  fluorescence  intensity  peak;  SAβ‐gal:  median  fluorescence 
intensity peak; Telomere  shortening: percentage of  shortening per population doubling; Telomere  length: 
the percentage compared to the reference cell line 
